The global share of corresponding/leading authorship in scientific publications in drug discovery shows notable variation across countries in 2023. Indonesia leads with a high percentage, while countries like the United States and major European nations display relatively lower figures. The data signifies regional dominance, with Asian countries often securing higher percentages. The variation over the years remains negligible, suggesting stability in the trend.
When projecting future trends, it is critical to monitor shifts in collaboration patterns and the emergence of new research hubs. Rising investment in research infrastructure among developing countries might impact global authorship dynamics in the coming years.
Top countries in Share of Corresponding/Leading Author in Scientific Publications in Drug Discovery by Country
| # | 10 Countries | Percent | Last Year | |
|---|---|---|---|---|
| 1 | 1 Indonesia | 99.81 | 2023 | View data |
| 2 | 2 China | 98.47 | 2023 | View data |
| 3 | 3 India | 97.13 | 2023 | View data |
| 4 | 4 South Korea | 96.92 | 2023 | View data |
| 5 | 5 Russia | 96.42 | 2023 | View data |
| 6 | 6 Japan | 95.68 | 2023 | View data |
| 7 | 7 Poland | 95.23 | 2023 | View data |
| 8 | 8 Italy | 94.6 | 2023 | View data |
| 9 | 9 Thailand | 94.2 | 2023 | View data |
| 10 | 10 Mexico | 94.15 | 2023 | View data |
